Form 4 for TMO Thermo Fisher Scientific
Accepted 2022-05-31 00:00:00 ET · period of report 2022-05-26 · accession 0001127602-22-016032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-31 | 2022-05-26+ | TMO | Lagarde Michel | EVP, COO | S - Sale+OE | $548.70 | -29.8K | 25.0K | -54% | -$16.35M |
| DM | 2022-05-31 | 2022-05-26+ | TMO | Lagarde Michel | EVP, COO | M - OptEx | $289.02 | +29.8K | 28.8K | New | +$8.61M |
| DM | 2022-05-31 | 2022-05-26+ | TMO | Lagarde Michel | EVP, COO | M - OptEx | $0.00 | -29.8K | 4,638 | -87% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-27 | S | D | 1,182 | $566.16 | 15,758.21 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.815 to $566.71, inclusive. |
| 2 | Common | Common Stock | 2022-05-27 | S | D | 8,731 | $565.18 | 16,940.21 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.70 to $565.69, inclusive. |
| 3 | Common | Common Stock | 2022-05-27 | S | D | 3,117 | $564.23 | 25,671.21 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $563.695 to $564.69, inclusive. |
| 4 | Common | Common Stock | 2022-05-27 | M | A | 9,137 | $309.63 | 24,895.21 | D | — | — | |
| 5 | Common | Common Stock | 2022-05-26 | S | D | 2,139 | $537.40 | 15,758.21 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.86 to $537.59, inclusive. |
| 6 | Common | Common Stock | 2022-05-26 | S | D | 7,083 | $536.25 | 17,897.21 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.86 to $536.85, inclusive. |
| 7 | Common | Common Stock | 2022-05-26 | S | D | 7,542 | $535.38 | 24,980.21 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.86 to $535.85, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), and (6) to this Form 4. |
| 8 | Common | Common Stock | 2022-05-26 | M | A | 10,715 | $253.99 | 32,522.21 | D | — | — | |
| 9 | Common | Common Stock | 2022-05-26 | M | A | 6,049 | $210.68 | 21,807.21 | D | — | — | |
| 10 | Common | Common Stock | 2022-05-27 | M | A | 3,893 | $458.81 | 28,788.21 | D | — | — | |
| 11 | Derivative | Stock Option (Right to Buy) | 2022-05-26 | M | D | 6,049 | $0.00 | 0 | D | $210.68 · — to 2025-02-27 | 6,049 Common Stock | (F8) The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022. |
| 12 | Derivative | Stock Option (Right to Buy) | 2022-05-27 | M | D | 9,137 | $0.00 | 9,138 | D | $309.63 · — to 2027-02-25 | 9,137 Common Stock | (F10) The option vests in four equal annual installments. One-quarter of the shares vested on February 25, 2021 and 2022, and the remaining two quarters will vest on February 25, 2023 and 2024. |
| 13 | Derivative | Stock Option (Right to Buy) | 2022-05-27 | M | D | 3,893 | $0.00 | 11,682 | D | $458.81 · — to 2028-02-23 | 3,893 Common Stock | (F9) The option vests in four equal annual installments. One-quarter of the shares vested on February 23, 2022, and the remaining three quarters will vest on February 23, 2023, 2024 and 2025. |
| 14 | Derivative | Stock Option (Right to Buy) | 2022-05-26 | M | D | 10,715 | $0.00 | 4,638 | D | $253.99 · — to 2026-02-26 | 10,715 Common Stock | (F7) The option vests in four equal annual installments. One-quarter of the shares vested on February 26, 2020, 2021 and 2022 and the remaining one-quarter will vest on February 26, 2023. |